Home > Boards > US Listed > Biotechs > Clearside BioMedical, Inc. (CLSD)

Yeah who is that cat talking about, if

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Yo-Yo Member Profile
 
Followed By 138
Posts 9,180
Boards Moderated 0
Alias Born 03/04/13
160x600 placeholder
Clearside Biomedical Announces Multiple Poster Presentations at the Association for Research in Vision and Ophthalmology 2021... GlobeNewswire Inc. - 5/10/2021 7:05:00 AM
Clearside Biomedical to Report First Quarter 2021 Financial Results and Provide Corporate Update on Monday, May 17, 2021 GlobeNewswire Inc. - 5/4/2021 7:05:00 AM
Clearside Biomedical resubmits eye treatment XIPERE NDA Seeking Alpha - 5/3/2021 7:36:58 AM
Clearside Biomedical Announces Resubmission of New Drug Application for XIPERE™ for Treatment of Macular Edema Associated w... GlobeNewswire Inc. - 5/3/2021 7:05:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/28/2021 9:24:29 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/28/2021 7:04:42 AM
Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD & DME Drug Development Summit GlobeNewswire Inc. - 4/5/2021 7:05:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/23/2021 5:16:59 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/15/2021 9:13:31 AM
Clearside Biomedical EPS misses by $0.03, misses on revenue Seeking Alpha - 3/10/2021 4:20:14 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/10/2021 4:11:22 PM
Clearside Biomedical Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 3/10/2021 4:05:00 PM
Clearside Biomedical completes dosing in early-stage wet AMD study cohort 1 Seeking Alpha - 3/2/2021 7:37:37 AM
Clearside Biomedical Announces Completion of Patient Dosing in First Cohort of Phase 1/2a Clinical Trial of CLS-AX (axitinib ... GlobeNewswire Inc. - 3/2/2021 7:05:00 AM
Clearside Biomedical to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update on Wednesday,... GlobeNewswire Inc. - 2/24/2021 7:05:00 AM
Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2021 GlobeNewswire Inc. - 2/23/2021 7:05:00 AM
Clearside Biomedical Announces CLS-AX (axitinib injectable suspension) Presentation Delivered at Angiogenesis, Exudation, and... GlobeNewswire Inc. - 2/16/2021 7:05:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/12/2021 6:24:27 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/12/2021 12:25:49 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2021 9:56:23 AM
Clearside Biomedical Featured in Multiple Data Presentations at the 44th Virtual Annual Macula Society Meeting GlobeNewswire Inc. - 2/8/2021 7:05:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/20/2021 6:20:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/20/2021 6:19:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/20/2021 6:18:10 PM
Clearside Biomedical Announces First Patients Enrolled in Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension... GlobeNewswire Inc. - 1/12/2021 7:05:00 AM
Yo-Yo   Sunday, 02/17/19 09:11:03 PM
Re: BioSpecialist post# 67
Post # of 235 
Yeah who is that cat talking about, if I buy 20,000 shares and it moves .20 cents to my favor is that bad CLSD!!!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences